المؤلفون: Woo SJ; Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul, Republic of Korea., Bradvica M; Clinical of Ophthalmology, Osijek University Hospital, Faculty of Medicine University of Osijek, Osijek, Croatia., Vajas A; Department of Ophthalmology, Clinical Center, University of Debrecen, Debrecen, Hungary., Sagong M; Department of Ophthalmology, Yeungnam University College of Medicine, Daegu, Republic of Korea., Ernest J; Department of Ophthalmology, Axon Clinical, Praha, Czech Republic., Studnicka J; Department of Ophthalmology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Veith M; Ophthalmology Clinic, Univerzity Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Charles Univerzity, Prague, Czech Republic., Wylegala E; Department of Ophthalmology, Gabinet Okulistyczny, Katowice, Poland., Patel S; Retina Research Institute of Texas, Abilen., Yun C; Department of Ophthalmology, Korea University Ansan Hospital, Ansan, Republic of Korea., Orski M; Department of Ophthalmology, Rydygier Memorial Hospital, Krakow, Poland., Astakhov S; Pavlov First State Medical University of St Petersburg, St Petersburg, Russia., Tóth-Molnár E; Albert Szent-Györgyi Medical Center, University of Szeged, Szeged, Hungary., Csutak A; Department of Ophthalmology, University of Pécs Medical School, Pécs, Hungary., Enyedi L; Bajcsy-Zsilinszky Korhaz es Rendelointezet, Budapest, Hungary., Kim T; Samsung Bioepis, Incheon, Republic of Korea., Oh I; Samsung Bioepis, Incheon, Republic of Korea., Jang H; Samsung Bioepis, Incheon, Republic of Korea., Sadda SR; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; University of California, Los Angeles.

المصدر: JAMA ophthalmology [JAMA Ophthalmol] 2023 Jul 01; Vol. 141 (7), pp. 668-676.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Biosimilar Pharmaceuticals*/adverse effects , Macular Degeneration*/drug therapy , Wet Macular Degeneration*/diagnosis , Wet Macular Degeneration*/drug therapy , Wet Macular Degeneration*/chemically induced, Humans ; Female ; Aged ; Male ; Angiogenesis Inhibitors/adverse effects ; Treatment Outcome ; Visual Acuity ; Intravitreal Injections ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Recombinant Fusion Proteins/adverse effects ; Ranibizumab/therapeutic use

المؤلفون: Bressler NM; Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, USA., Veith M; Department of Ophthalmology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.; Department of Ophthalmology, Third Faculty of Medicine, Charles University, Prague, Czech Republic., Hamouz J; Department of Ophthalmology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.; University Hospital Kralovske Vinohrady, Praha, Czech Republic., Ernest J; Department of Ophthalmology, Central Military Hospital, Praha, Czech Republic., Zalewski D; Diagnostic and Microsurgery Center of the Eye LENS, Olsztyn, Poland., Studnička J; Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.; University Hospital Hradec Kralove, Hradec Kralove, Královéhradecký, Czech Republic., Vajas A; Department of Ophthalmology, University of Debrecen, Debrecen, Hajdú-Bihar, Hungary., Papp A; Department of Ophthalmology, Semmelweis University, Budapest, Hungary., Vogt G; Department of Ophthalmology, Hungarian Defence Forces Medical Centre, Budapest, Hungary., Luu J; Retina Consultants of Southern Colorado PC, Colorado Springs, Colorado, USA., Matuskova V; Department of Ophthalmology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; University Hospital Brno, Brno, Czech Republic., Yoon YH; Department of Ophthalmology, Asan Medical Center, Songpa-gu, Seoul, South Korea.; University of Ulsan College of Medicine, Songpa-gu, Seoul, South Korea., Pregun T; Department of Ophthalmology, Bajcsy-Zsilinszky Hospital and Clinic, Budapest, Hungary., Kim T; Samsung Bioepis Co Ltd, Incheon, South Korea., Shin D; Samsung Bioepis Co Ltd, Incheon, South Korea., Oh I; Samsung Bioepis Co Ltd, Incheon, South Korea., Jeong H; Samsung Bioepis Co Ltd, Incheon, South Korea., Kim MY; Samsung Bioepis Co Ltd, Incheon, South Korea., Woo SJ; Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea sejoon1@snu.ac.kr.; Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.

المصدر: The British journal of ophthalmology [Br J Ophthalmol] 2023 Mar; Vol. 107 (3), pp. 384-391. Date of Electronic Publication: 2021 Oct 16.

نوع المنشور: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Biosimilar Pharmaceuticals*/therapeutic use , Macular Degeneration*/drug therapy , Wet Macular Degeneration*/diagnosis , Wet Macular Degeneration*/drug therapy, Humans ; Middle Aged ; Ranibizumab/therapeutic use ; Angiogenesis Inhibitors/therapeutic use ; Vascular Endothelial Growth Factor A ; Visual Acuity ; Intravitreal Injections ; Treatment Outcome

المؤلفون: Ernest J; Department of Ophthalmology, Military University Hospital Prague, Prague, Czechia.; Axon Clinical Ltd., Clinical Research Centre, Prague, Czechia., Manethova K; Department of Ophthalmology, Military University Hospital Prague, Prague, Czechia.; Axon Clinical Ltd., Clinical Research Centre, Prague, Czechia., Kolar P; Department of Ophthalmology, University Hospital Brno, Brno, Czechia., Sobisek L; Department of Statistics and Probability, University of Economics in Prague, Prague, Czechia., Sacconi R; Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy., Querques G; Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy, giuseppe.querques@hotmail.it.

المصدر: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde [Ophthalmologica] 2020; Vol. 243 (1), pp. 58-65. Date of Electronic Publication: 2019 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0054655 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0267 (Electronic) Linking ISSN: 00303755 NLM ISO Abbreviation: Ophthalmologica Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Macula Lutea/*pathology , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Retinal Pigment Epithelium/*pathology , Wet Macular Degeneration/*drug therapy, Aged ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Retrospective Studies ; Tomography, Optical Coherence ; Wet Macular Degeneration/diagnosis

المؤلفون: Jaki Mekjavić P; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia. Electronic address: polona.jaki@guest.arnes.si., Jūratė Balčiūnienė V; Eye Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania., Ćeklić L; Ministry of Health of Republic of Srpska, Barja Luka, Bosnia and Herzegovina., Ernest J; Central Military Hospital, Prague, Czech Republic., Jamrichova Z; Faculty Hospital Bratislava, Bratislava, Slovakia., Zsolt Nagy Z; Department of Ophthalmology, Semmelweis University, Budapest, Hungary; Department of Clinical Ophthalmology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary., Petkova I; University Eye Hospital Sofia, Sofia, Bulgaria., Teper S; Medical University of Silesia, Katowice, Poland., Gardašević Topčić I; General Hospital Novo mesto, Novo mesto, Slovenia., Veith M; Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.

المصدر: Value in health regional issues [Value Health Reg Issues] 2019 Sep; Vol. 19, pp. 1-6. Date of Electronic Publication: 2019 Jan 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE

مواضيع طبية MeSH: Cost of Illness*, Delivery of Health Care/*economics , Health Policy/*economics , Macular Edema/*epidemiology , Wet Macular Degeneration/*epidemiology, Europe/epidemiology ; Guidelines as Topic/standards ; Humans ; Reimbursement Mechanisms ; Retinal Diseases/therapy

المؤلفون: Timothy L, Jackson, Usha, Chakravarthy, Peter K, Kaiser, Jason S, Slakter, Ernest, Jan, Francesco, Bandello, Denis, O'Shaughnessy, Michael E, Gertner, Linda, Danielson, Darius M, Moshfeghi, Yit, Yang

المصدر: Ophthalmology. 120(9)

مصطلحات موضوعية: Male, Visual Acuity, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Radiosurgery, Combined Modality Therapy, Treatment Outcome, Double-Blind Method, Ranibizumab, Intravitreal Injections, Retreatment, Wet Macular Degeneration, Humans, Female, Fluorescein Angiography, Tomography, Optical Coherence, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::6e38b0844cc346fedaf6d7e952935d31
https://pubmed.ncbi.nlm.nih.gov/23490327